Across TCGA pan-cancer cohorts, RNA5SP219 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNA5SP219’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNA5SP219 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP219 is over-expressed in tumor, although a few such as BRCA and KIRC show the opposite, repressed pattern.

STAD, HNSC, and BRCA are the cancer types where RNA5SP219 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP219 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.957	<.001	6	view →
HNSC	Male	All	+0.842	<.001	6	view →
BRCA	All	III,IV	−0.798	<.001	6	view →
KICH	All	II,III,IV	+0.522	.021	1	view →
KIRC	Female	II,III,IV	−0.515	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNA5SP219 RNA expression & survival · all RNA5SP219 data types